Skip to main content

Syndicate contenttuberculosis

TB vaccine gets its groove back

A team of Vanderbilt University Medical Center investigators has cracked one of clinical medicine's enduring mysteries ? what happened to the tuberculosis vaccine.

Filling the gap: The importance of Medicaid continuity for former inmates

PROVIDENCE, RI ? It is time for states to suspend, rather than terminate, the Medicaid benefits of inmates while they are incarcerated, say correctional health care experts from The Miriam Hospital in a commentary published online by the Journal of General Internal Medicine.

Infection control 'urgently needed' to curb spread of XDR-TB among health care workers

ATS 2009, SAN DIEGO?Healthcare workers in South Africa are at a significantly increased risk of developing drug-resistant tuberculosis, or XDR-TB, in a trend which threatens to further exacerbate the already beleaguered healthcare systems in sub-Saharan countries, according to results of a new study.

AIDS patients with serious complications benefit from early retroviral use, Stanford study shows

STANFORD, Calif. - HIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University School of Medicine.

Excluding the lateral view in chest radiograph screenings decreases radiation exposure by 67 percent

For the patient with a positive PPD test, which usually indicates prior exposure to tuberculosis, the guidelines recommend a chest x-ray that typically includes a frontal and lateral view. The lateral view, which accounts for 2/3 of the total radiation dose during screening, is not necessary, according to a study performed at the Beth Israel Deaconess Medical Center in Boston, MA.

UI chemists' DNA biosynthesis discovery could lead to better antibiotics

Combating several human pathogens, including some biological warfare agents, may one day become a bit easier thanks to research reported by a University of Iowa chemist and his colleagues in the April 16 issue of the journal Nature.

Slow-growing TB bacteria point the way to new drug development

The discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB), in the lungs of TB patients could be an important step forward in the design of new anti-TB drugs.

Discovery of tuberculosis bacterium enzyme paves way for new TB drugs

COLLEGE PARK, Md., March 27 (AScribe Newswire) -- A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease.

U-M researcher's idea jells into potential new disease-detection method

ANN ARBOR, Mich.---Relying on principles similar to those that cause Jell-O to congeal into that familiar, wiggly treat, University of Michigan researchers are devising a new method of detecting nitric oxide in exhaled breath.

TB vaccine developed at McMaster University in Canada

Hamilton, ON (March 19, 2009) - McMaster University researchers are about to launch Canada's first tuberculosis (TB) vaccine clinical trial with a vaccine totally designed, manufactured and tested within McMaster.

Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time

March 19, 2009 - (BRONX, NY) - Researchers from the Albert Einstein College of Medicine and The University of Pittsburgh have developed an onsite method to quickly diagnose tuberculosis (TB) and expose the deadly drug-resistant strains that can mingle undetected with treatable TB strains.

TB breakthrough could lead to stronger vaccine

A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine's Advance Online Publication March 1.

New discovery gives tuberculosis vaccine a shot in the arm

A new article appearing in the March 2009 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) may lead to improvements in the efficacy of the current tuberculosis vaccine.

In India: A search for more effective tuberculosis drugs

Rajesh Gokhale has created a compound in his lab in India that stops tuberculosis in its tracks. In a test tube, the molecule hits four of the bacterium's crucial metabolic pathways at the same time, weakening and ultimately destroying the pathogen.

PulmoNet Beta is now online

February 1, 2009 by vinodscaria

vinodscaria's picture


PulmoNet|Online Collaboration Portal and Social Network for Medical Professionals and Healthcare workers working on Tuberculosis
PulmoNet is an online Social Network and Collaboration Platform for pulmonologists and Healthcare professionals working in the field of Tuberculosis and Chest Diseases.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes